Research use only, not for human consumption. Email [email protected]
← Research status explorer
Neuro / Cognitive

DSIP

Also known as: Emideltide, Delta sleep-inducing peptide

Current research status Human Research
Historical human research
Preclinical
Human Research

Overview

DSIP (delta sleep-inducing peptide, sometimes called emideltide) was studied in human sleep research from the 1970s through the 1990s, including trials on sleep architecture and, in some studies, growth hormone release. Findings have been mixed — one human study found DSIP did not significantly affect GH or prolactin secretion in normal women — and it has not been developed into an approved product.

Key research

Last reviewed: September 2026